Brief: Inhibrx To Host Webcast Presentation To Provide Clinical Update On Ozekibart In Late Line Colorectal Cancer
20/04/2026 23:10
April 20 (Reuters) - Inhibrx Biosciences Inc INBX.O: INHIBRX TO HOST WEBCAST PRESENTATION TO PROVIDE CLINICAL UPDATE ON OZEKIBART (INBRX-109) IN LATE LINE COLORECTAL CANCER Source text: ID:nPn26g0kBa Further company coverage: INBX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibrx Biosciences
See all newsInhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study (updated)
Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study
NASDAQ RESUMED AT 08:00 AM
Brief: Inhibrx's Inbrx-106 Nearly Doubles Response Rate And Achieves Interim Median Pfs Of 9.6 Months In Phase 2 Hnscc Study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM